View More View Less
  • 1 Group for Medical Entomology, Centre of Excellence for Food and Vector Borne Zoonoses, Institute for Medical Research, University of Belgrade, Belgrade, Serbia
  • | 2 Laboratory for Diagnostics of Borreliosis and Leptospirosis, Institute for Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

Abstract

In the present study, the effectiveness of six antimicrobial agents have been tested against 24 borrelia strains isolated from Ixodes ricinus ticks (11 Borrelia lusitaniae, eight Borrelia afzelii, three Borrelia garinii and two Borrelia valaisiana) and one B. lusitaniae strain isolated from human skin. The minimum inhibitory concentration range of antimicrobial agents was as follows: amoxicillin, 0.125–2 mg/L; doxycycline, 0.125–1 mg/L, ceftriaxone, 0.016–0.063 mg/L; cefuroxime, 0.063–1 mg/L; azithromycin, 0.0017–0.11 mg/L; amikacin 32–512 mg/L. Potentially pathogenic B. lusitaniae and B. valaisiana species were more susceptible to amoxicillin and azithromycin than pathogenic B. afzelii and B. garinii (P < 0.05); B. garinii, B. lusitaniae and B. valaisiana were more susceptible to doxycycline than B. afzelii (P < 0.05) while all species showed same susceptibility to ceftriaxone and cefuroxime (P > 0.05). This study is the first report on in vitro susceptibility of isolates from Serbia to antimicrobial agents and the first report on susceptibility of larger number of isolates of potentially pathogenic species B. lusitaniae. We showed that antimicrobial agents in vitro inhibit growth of borrelia strains very effectively, indicating the potential of their equally beneficial use in the treatment of Lyme borreliosis.

  • 1.

    Stanek G , Wormser GP , Gray J , Strle F . Lyme borreliosis. Lancet 2012; 379: 46173.

  • 2.

    Steere AC , Strle F , Wormser GP , Hu LT , Branda JA , Hovius JW , et al. Lyme borreliosis. Nat Rev Dis Primers 2016; 2: 16090.

  • 3.

    Collares–Pereira M , Couceiro S , Franca I , Kurtenbach K , Schäfer SM , Vitorino L , et al. First isolation of Borrelia lusitaniae from a human patient. J Clin Microbiol 2004; 42: 131618.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    van den Wijngaard CC , Hofhuis A , Simões M , Rood E , van Pelt W , Zeller H , et al. Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area. Eurosurveillance 2017; 22: 30569.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Lohr B , Fingerle V , Norris DE , Hunfeld KP . Laboratory diagnosis of Lyme borreliosis: Current state of the art and future perspectives. Crit Rev Clin Lab Sci 2018; 55: 21945.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Fehér Z , Toldy E , Schneider F . Evaluation of the epidemiological and clinical characteristics of central nervous system infections in adults in the West Pannonian region. Orv Hetil 2019; 160: 157483.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Institute for Public Health of Serbia. http://www.batut.org.rs/download/izvestaji/Godisnji%20izvestaj%20zarazne%20bolesti%202017.pdf[in Serbian] (accessed February 10 2021).

  • 8.

    Stanek G , Strle F . Lyme borreliosis-from tick bite to diagnosis and treatment. FEMS Microbiol Rev 2018; 42: 23358.

  • 9.

    Mladenović J . Epidemiological aspects of Lyme disease on the territory of Belgrade city. Doctoral dissertation, Faculty of Medicine, University of Nis, Serbia. 2014; p. 64. [in Serbian].

    • Search Google Scholar
    • Export Citation
  • 10.

    Estrada-Peña A , Cutler S , Potkonjak A , Vassier–Tussaut M , Van Bortel W , Zeller H , et al. An updated meta-analysis of the distribution and prevalence of Borrelia burgdorferi s.l. in ticks in Europe. Int J Health Geogr 2018; 17: 41.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Milutinović M , Masuzawa T , Tomanović S , Radulović Ž , Fukui T , Okamoto Y . Borrelia burgdorferi sensu lato, Anaplasma phagocytophilum, Francisella tularensis and their co-infections in host-seeking Ixodes ricinus ticks collected in Serbia. Exp Appl Acarol 2008; 45: 17183.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12.

    Ćakić S , Veinović G , Cerar T , Mihaljica D , Sukara R , Ružić–Sabljić E , et al. Diversity of Lyme borreliosis spirochetes isolated from ticks in Serbia. Med Vet Entomol 2019; 33: 51220.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Dersch R , Freitag MH , Schmidt S , Sommer H , Rücker G , Rauer S , et al. Efficacy and safety of pharmacological treatments for neuroborreliosis–protocol for a systematic review. Syst Rev 2014; 3: 117.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Torbahn G , Hofmann H , Allert R , Freitag MH , Dersch R , Fingerle V , et al. Efficacy and safety of pharmacological agents in the treatment of erythema migrans in early Lyme borreliosis-systematic review protocol. Syst Rev 2016; 5: 73.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    Trott DJ , Abraham S , Adler B . Antimicrobial resistance in Leptospira, Brucella, and other rarely investigated veterinary and zoonotic pathogens. Microbiol Spectr 2018; 6. https://doi.org/10.1128/microbiolspec.ARBA-0029-2017.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Hunfeld KP , Kraiczy P , Wichelhaus TA , Schäfer V , Brade V . Colorimetric in vitro susceptibility testing penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates. Int J Antimicrob Agents 2000; 15: 117.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17.

    Morgenstern K , Baljer G , Norris DE , Kraiczy P , Hanssen–Hübert C , Hunfeld KP . In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease. Antimicrob Agents Chemother 2009; 53: 128184.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18.

    Sicklinger M , Wienecke R , Neubert U . In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto. J Clin Microbiol 2003; 41: 179193.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Ruzić–Sabljić E , Podreka T , Maraspin V , Strle S . Susceptibility of Borrelia afzelii strains to antimicrobial agents. Int J Antimicrob Agents 2005; 25: 4748.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20.

    Veinović G , Cerar T , Strle F , Lotrič–Furlan S , Maraspin V , Cimperman J , et al. In vitro susceptibility of European human Borrelia burgdorferi sensu stricto strains to antimicrobial agents. Int J Antimicrob Agents 2013; 41: 28891.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21.

    Yang X , Nguyen A , Qiu D , Luft BJ . In vitro activity of tigecycline against multiple strains of Borrelia burgdorferi. J Antimicrob Chemother 2009; 63: 70912.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22.

    Hunfeld KP , Ružić–Sabljić E , Norris DE , Kraiczy P , Strle F . In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy. Antimicrob Agents Chemother 2005; 49: 1294301.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23.

    Preac–Mursic V , Marget W , Busch U , Pleterski–Riegler D , Hage S . Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis. Infection 1996; 24: 916.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24.

    Barral M , García–Pérez AL , Juste RA , Hurtado A , Escudero R , Sellek RE , et al. Distribution of Borrelia burgdorferi sensu lato in Ixodes ricinus (Acari: Ixodidae) ticks from the Basque Country, Spain. J Med Entomol 2002; 39: 17784.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25.

    Escudero R , Barral M , Pérez A , Vitutia MM , García–Pérez AL , Jiménez S , et al. Molecular and pathogenic characterization of Borrelia burgdorferi sensu lato isolates from Spain. J Clin Microbiol. 2000; 38: 402633.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26.

    Nuncio MS , Péter O , Alves MJ , Bacellar F , Filipe AR . Isolamento e caracterizaçao de Borrélias de Ixodes ricinus L. em Portugal. Rev Portuguesa Doenças Infecc 1993; 16: 1759.

    • Search Google Scholar
    • Export Citation
  • 27.

    Hunfeld KP , Brade V . Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don’t know, and what we need to know. Wien Klin Wochenschr 2006; 118: 65968.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28.

    Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 10th ed., CLSI Wayne, PA; 2015.

    • Search Google Scholar
    • Export Citation
  • 29.

    Jorgensen JH , Turnidge JD : Susceptibility test methods: dilution and disk diffusion methods. In: Jorgensen JH , Carroll KC , Funke G , Pfaller MA , Landry ML , Richter SS , Warnock DW , editors. Manual of clinical microbiology. 11th ed. Washington DC: American Society for Microbiology Press, 2015, pp. 125373.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30.

    Boerner J , Failing K , Wittenbrink MM . In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: influence of test conditions on minimal inhibitory concentration (MIC) values. Zentralbl Bakteriol 1995; 283: 4960.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31.

    Hunfeld KP , Rödel R , Wichelhaus TA . In vitro activity of eight oral cephalosporins against Borrelia burgdorferi. Int J Antimicrob Agents 2003; 21: 31318.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32.

    Ates L , Hanssen-Hübner C , Norris DE , Richter D , Kraiczy P , Hunfeld KP . Comparison of in vitro activities of tigecycline, doxycycline, and tetracycline against the spirochete Borrelia burgdorferi. Ticks Tick Dis 2010; 1: 304.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33.

    Lallemand EA , Lacroix MZ , Toutain PL , Boullier S , Ferran AA , Bousquet–Melou A . In vitro degradation of antimicrobials during use of broth microdilution method can increase the measured minimal inhibitory and minimal bactericidal concentrations. Front Microbiol 2016; 7: 2051.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 34.

    Schmidt S , Röck K , Sahre M , Burkhardt O , Brunner M , Lobmeyer MT , et al. Effect of protein binding on the pharmacological activity of highly bound antibiotics. Antimicrob Agents Chemother 2008; 52: 39944000.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 35.

    Arnež M , Ružić–Sabljić E . Azithromycin is equally effective as amoxicillin in children with solitary erythema migrans. J Pediatr Infect Dis 2015; 34: 10458.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 36.

    Cerar T , Strle F , Stupica D , Ružić–Sabljić E , McHugh G , Steere AC , et al. Differences in genotype, clinical features, and inflammatory potential of Borrelia burgdorferi sensu stricto strains from Europe and the United States. Emerg Infect Dis 2016; 22: 81827.

    • Crossref
    • Search Google Scholar
    • Export Citation

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 652 EUR / 812 USD
Subscription fee 2022 Online subsscription: 662 EUR / 832 USD
Print + online subscription: 740 EUR / 930 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
May 2021 0 0 0
Jun 2021 0 0 0
Jul 2021 0 0 0
Aug 2021 0 0 0
Sep 2021 75 5 7
Oct 2021 20 0 0
Nov 2021 0 0 0